Evidence map›Paper›PMID 34721041›Full record

ArticleFrontiers in pharmacology2021

Based on Activation of p62-Keap1-Nrf2 Pathway, Hesperidin Protects Arsenic-Trioxide-Induced Cardiotoxicity in Mice.

Yuxin Jia, Jing Li, Panpan Liu, Mingdong Si, Yanyu Jin, Hongfang Wang, Donglai Ma, Li Chu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Hesperidin ameliorates HJournal of animal science and biotechnology · 2024
    Article
  7. Review
  8. Article
  9. NFE2L2 and ferroptosis resistance in cancer therapy.Cancer drug resistance (Alhambra, Calif.) · 2024
    Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. The Mechanism of TNF-Oxidative medicine and cellular longevity · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yuxin JiaSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Jing LiSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Panpan LiuSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Mingdong SiSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Yanyu JinSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Hongfang WangSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Donglai MaSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Li ChuSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Hebei University of Chinese Medicine · CNHebei Science and Technology Department · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

arsenic trioxidecardiotoxicityhesperidinoxidative stressp62-Keap1-Nrf2 pathway

Identifiers

PMID34721041
PMCPMC8548645
OpenAlexW3207095030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.